Measuring BGM Success: KPIs and ROI
How do I measure the success of my BGM program — and how do I calculate ROI for leadership?
BGM ROI can be benchmarked against peer-reviewed studies: IGA Report 40 puts the European median return at 1:2.7 (€1 in → €2.70 back, 140 studies). Under German law, GKV requires structure, process, and outcome evaluation for §20b funding — participant counts alone aren't enough.
BGM KPI System: Hard and Soft Metrics at a Glance
| KPI | Measurement Method | Target / Benchmark | Data Source | Reporting |
|---|---|---|---|---|
| Sick-Leave Rate (%) | Sick days / (working days × employees) × 100 | Below industry average (GKV Health Report) | Payroll / HR system | Quarterly |
| Sick Days per Employee | Total sick days / number of employees | National average 2024: 19.1 days (TK Health Report 2025) | Payroll | Annually, year-over-year comparison |
| BEM Rate (%) | BEM cases initiated / BEM-eligible cases × 100 | ≥ 90% (mandatory under §167(2) SGB IX) | BEM case log / HR | Semi-annually |
| Initiative Participation Rate | Participants / target group × 100 | ≥ 20% per initiative (GKV Guideline minimum) | Registration system / initiative log | Per initiative |
| Self-Reported Health (NPS) | Employee survey: 0–10 scale | Improvement over prior year; target ≥ 7 | Anonymous survey | Annually |
| BGM ROI (€ per € invested) | Chapman formula (see Section 3) | IGA median (Europe): 1:2.7 — Chapman (US): 1:5.56 | Cost accounting + sick-leave data | Annually |
The KPI Problem: Why Participant Counts Don't Convince Leadership
After every health day, the same slide lands on the table: '340 employees took part — that's 68 percent of the workforce.' What that sentence doesn't answer: Did it change anything? Is sick leave dropping? Are there fewer back-related absences? Has morale improved?
Participant counts are a process metric — they show whether offerings were accepted. They say nothing about impact. Leadership decides on budgets. They need outcome metrics, not an event calendar.
On this point, the GKV Prevention Guideline (a German statutory health insurance framework) is unambiguous: process funding under §20b SGB V requires evidence of evaluation covering all three levels — structure, process, and outcome. Providing only participant counts won't get you a subsidy.
The 3 Evaluation Levels of the GKV Guideline in Detail
The 2025 GKV Prevention Guideline (Phase 5, checkpoints #42–#52) distinguishes three evaluation levels that build on each other hierarchically. Measuring only the third level without securing the first is building on sand.
Level 1 — Structure evaluation: Was the BGM governance system active? Did the health steering committee meet with the legally required quorum (§1 ASiG, §20b SGB V)? Typical metrics: number of committee meetings, leadership attendance rate, works council participation.
Level 2 — Process evaluation: Did initiatives reach the right target groups? Were shift workers, older employees, and staff without desk jobs taken into account? Metrics: participation rates broken down by target group, barrier-reduction measures.
Level 3 — Outcome evaluation: What changed measurably? Year-over-year sick-leave rate, trends in self-reported health scores, BEM rate, turnover rate. Important: name correlation, not unwarranted causation.
Calculating ROI — the Chapman Formula for Mid-Sized Companies
The Chapman meta-analysis (2012, n = 56 studies) is the most-cited ROI evidence in workplace health management practice: on median, a company saves €5.56 in absence and illness costs for every euro invested in workplace health promotion.
For your own ROI calculation you need three figures: (A) Average fully-loaded cost of one sick day (wages + benefits + productivity loss) — rule of thumb: gross daily wage × 1.8. (B) Number of sick days avoided compared to the prior year or industry average. (C) Total investment in workplace health management (initiatives + coordination time + external costs).
Formula: ROI = [(A × B) − C] / C × 100%. Example: 100 employees, gross daily wage €200, 0.5 sick days avoided per employee = 100 × 200 × 1.8 × 0.5 = €18,000 in savings. Workplace health investment: €12,000. ROI = [(18,000 − 12,000) / 12,000] × 100 = 50%. That equates to a 1.5:1 return — conservative, but credible in a leadership conversation.
Reality check: the Chapman figure of 5.56:1 came from US studies, often based on multi-year programs. For the first year of workplace health management at a mid-sized German company, an ROI of 1.5:1 to 2.5:1 is realistic. Communicating that clearly is more credible than citing unsubstantiated US numbers.
Balanced Scorecard: When Workplace Health Management Becomes Strategic
From 50 employees onward, the GKV Guideline (checkpoint #52) recommends using a balanced scorecard — a governance system that frames workplace health management not as a one-off project but as a strategic dimension.
A BGM balanced scorecard has four perspectives: (1) Financial perspective: ROI, absence costs, BEM costs vs. turnover costs. (2) Employee perspective: satisfaction, health perception, engagement. (3) Process perspective: steering committee activity, initiative completion rate, GKV compliance. (4) Learning and development perspective: BGM competence at the leadership level, knowledge building, innovation measures.
The advantage of the balanced scorecard: it prevents workplace health management from being reduced to cost-cutting. Companies that only optimize sick-leave rates lose sight of the real goal — health as a value driver. The scorecard keeps all four dimensions visible at once.
Evaluation as a GKV Funding Requirement: What the Insurer Wants to See
For process funding under §20b SGB V, German statutory health insurers require evaluation evidence that goes beyond a single initiative's closing report. They want to see that workplace health management runs as a continuous system — not as an annual campaign.
The health-economic evaluation (checkpoint #51) can take the form of a cost-benefit analysis (monetary: ROI) or a cost-effectiveness analysis (non-monetary: sick days, survey scores). Both are acceptable — for leadership reports, the cost-benefit analysis is more persuasive; for health-insurer applications, cost-effectiveness analysis is often sufficient.
Tip: ask your health insurer early which evaluation format it accepts for the funding application. AOK, TK, BKK, and IKK sometimes use different forms — what counts as evidence at one insurer may not be enough at another. Contact is usually made through the insurer's workplace health advisor.
Tools and Instruments for Workplace Health Evaluation
For employee surveys, the GKV Guideline recommends scientifically validated instruments. Proven in mid-sized German companies: the Copenhagen Psychosocial Questionnaire (COPSOQ) for psychosocial strain, the Work Ability Index (WAI) for older workforces, and short product-specific questionnaires (3–5 questions) for mid-year pulse checks.
For absence analysis, the HR system is sufficient in many SMEs. Using the health reports provided by German statutory insurers gets you aggregated data by occupational group and diagnosis category — free of charge, GDPR-compliant, and available once an insurer has roughly 20 or more insured employees at the company.
For demonstrating ROI to leadership: a simple spreadsheet calculation with the three Chapman parameters (daily sick-day cost, sick days avoided, investment) is sufficient and transparent. External expert reports are only necessary at large enterprises under dedicated controlling pressure.
- COPSOQ: Psychosocial strain — free online questionnaire, validated
- Work Ability Index (WAI): Work ability of older employees
- GKV health reports: Free, from ~20 insured employees, broken down by diagnosis
- Chapman ROI calculation: 3 parameters, spreadsheet-ready, leadership-conversation-ready
- Balanced Scorecard: Strategic workplace-health controlling, recommended from 50 employees (GKV Guideline)
Quick check
What's your company's workplace-health maturity?
Your maturity level decides whether your measures qualify for the tax-free €600 budget. Answer in 3 minutes — no sign-up.
Start maturity check (3 min.)Related measures & topics
Key takeaways
- Participant counts alone aren't evaluation — German statutory health insurers (GKV) require three levels: structure, process, outcome.
- BGM ROI: IGA Report 40 cites a European median of 1:2.7 — realistically 1.5:1 for SMEs in their first year.
- Fully-loaded sick-day cost: gross daily wage × 1.8 — roughly €373 per sick day at a €3,600 gross salary.
- From 50 employees: balanced scorecard recommended (GKV Guideline checkpoint #52) — four perspectives instead of a pure cost focus.
- Use the GKV health report for free: aggregated diagnosis data, GDPR-compliant, from ~20 insured employees.
- §20b funding application: full evaluation evidence due by end of March — only one level documented means rejection.
Frequently asked questions
What's the average workplace-health-management ROI at mid-sized German companies?+
The Chapman meta-analysis (2012) found a median ROI of 5.56:1 — for multi-year US programs. German SMEs in their first year of workplace health management should realistically expect 1.5:1 to 2.5:1. What matters isn't the absolute figure but the year-over-year trend and the comparison against alternative costs (recruiting, BEM proceedings).
What does a sick day actually cost — i.e., the true fully-loaded cost?+
Rule of thumb: gross daily wage × 1.8. At an average gross salary of €3,600/month, that's roughly €207 in daily wage × 1.8 = roughly €373 per sick day. The 1.8 factor captures benefits, continued wage payment, and estimated productivity effects on colleagues (overtime, covering shifts). Exact calculations with your own controlling department are always more precise.
Is the internal sick-leave rate enough evaluation evidence for §20b?+
No — German statutory health insurers (GKV) require all three evaluation levels. The sick-leave rate is an outcome metric (level 3). Without structure and process evaluation (levels 1 and 2), the evidence is incomplete. Insurers reject funding applications if only one level is documented.
Can the works council refuse to release workplace-health metrics?+
Under German law, the works council has co-determination rights under §87 BetrVG when introducing or changing systems for monitoring employee conduct or performance — employee surveys can fall under this. Fully anonymized, aggregated metrics (company-wide sick-leave rate) are generally not subject to co-determination. Recommendation: involve the works council early and put a works agreement on workplace health management in place.
How often should a workplace-health KPI report be produced?+
Quarterly for the steering committee (health working group): operational management. Semi-annually for HR leadership: trend analysis, BEM rate, initiative progress. Annually for leadership: full evaluation report with ROI, year-over-year comparison, continuous-improvement chapter. For the GKV funding application: once at year-end, submission by end of March recommended.
Automatically Capture BGM Metrics
EasyBGM logs initiatives, BEM case histories, and steering committee meetings — then generates the GKV-compliant evaluation report at the push of a button.
Sources
- IGA Report 40 — ROI of Workplace Health Promotion (Europe): Median 1:2.7 from 140 Studies ↗
- Chapman L.S. (2012): Meta-Evaluation of Worksite Health Promotion Economic Return Studies (US) ↗
- GKV Prevention Guideline 2025 — Phase 5: Evaluation (§20b SGB V) ↗
- TK Health Report 2025 (2024 Sick-Leave Report) — 19.1 sick days per employed person ↗
Last updated: 2026-06-24. Not legal or tax advice — have your specific case reviewed by a professional.